Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement
B. I. ERIKSSON, L. BORRIS, O. E. DAHL, S. HAAS, M. V. HUISMAN, A. K. KAKKAR, F. MISSELWITZ, P. KÄLEBO, FOR THE ODIXA-HIP STUDY INVESTIGATORSVolume:
4
Year:
2006
Language:
english
Pages:
8
DOI:
10.1111/j.1538-7836.2005.01657.x
File:
PDF, 182 KB
english, 2006